Biolife Solutions Inc (BLFS) — Institutional Holders Breakdown (Q2 2026)

BLFS ranks #2794 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

BLFS is a top-conviction position for Casdin Capital, LLC — at 6.6% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in BLFS belongs to T. Rowe Price Investment Management, Inc., but the position matters far more to Casdin Capital, LLC, who has 6.6% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Bank Of America CORP /de/ has added to its BLFS position for two straight quarters, increasing it by $14.2M to reach $26.8M today.

Ameriprise Financial Inc has trimmed its BLFS position for two straight quarters, cutting it by $20.0M while still holding $1.9M.

BLFS is up 1.3% today, and institutions have been net buyers of $61.4M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

BLFS posted net income of $58.0M over the trailing twelve months, and currently trades at a P/E of 30.1.

• Profitable — net income of $58.0M over the trailing twelve months
• Revenue declined 30.8% year over year
• Net income improved year over year, from -$5.5M to $58.0M
• Generated $20.1M in positive operating cash flow
• Current ratio of 5.94x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.09x equity — within a conventional range